Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Plasma cell × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 6 Breast 6 Other hematologic neoplasm 5 Thoracic 3 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Myeloid 1

Conditions

Multiple Myeloma 176 Lymphoma 20 Recurrence 16 Immunoglobulin Light-chain Amyloidosis 14 Hematologic Neoplasms 13 Neoplasms, Plasma Cell 11 Lymphoma, Non-Hodgkin 11 Leukemia, Myeloid, Acute 9 Smoldering Multiple Myeloma 7 Neoplasms 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Hodgkin Disease 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myelodysplastic Syndromes 5 Leukemia 5 Amyloidosis 5 Primary Myelofibrosis 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Waldenstrom Macroglobulinemia 3 Sarcoma 3 Prostatic Neoplasms 3 Paraproteinemias 3 Myeloproliferative Disorders 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Lung Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3

Interventions

isatuximab 1 Lenalidomide 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05690984 2026-03-16

EMAT

Medical College of Wisconsin

Phase 2 Active not recruiting

Multiple Myeloma, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡